Temitope Adeloye

Tope did a BA in Biological and Biomedical Sciences/Pharmacology in 2008. She qualified in medicine, University of Cambridge, in 2011. She joined HMR in 2015 as a Screening and Research Physician. In 2019 she passed the Diploma in Pharmaceutical Medicine with Distinction. In 2020 we promoted her to Senior Research Physician, Principal Investigator, and Head of Pharmacovigilance. Tope is accredited by the MHRA as PI for FIH studies.

Tope has been investigator or co-investigator for many early-phase clinical studies of small molecules or biological products. Se has worked on a wide range of studies, including FIH, PET, bridging, bioequivalence, drug-drug interaction, thorough QT, and studies involving administration of vaccines or radioactive compounds.

Tope is Visiting Lecturer in Clinical Pharmacology, Barts Hospital Medical College and Queen Mary University, London, for the MSc course in early drug development.

Tope has written or co-authored several papers on clinical pharmacology and drug development.